limonene has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimullah, S; Beiram, R; Eddin, LB; Jha, NK; Nagoor Meeran, MF; Ojha, S | 1 |
| De Caro, V; Giandalia, G; Giannola, LI; Siragusa, MG; Sutera, FM | 1 |
2 other study(ies) available for limonene and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats.
Topics: Animals; Apoptosis; Dopaminergic Neurons; Glutathione; Hippo Signaling Pathway; Limonene; Monoterpenes; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; Rats; Rotenone | 2023 |
New prospective in treatment of Parkinson's disease: studies on permeation of ropinirole through buccal mucosa.
Topics: Adjuvants, Pharmaceutic; Administration, Buccal; Animals; Antiparkinson Agents; Cyclohexenes; Drug Delivery Systems; Electricity; Feasibility Studies; Indoles; Iontophoresis; Limonene; Models, Biological; Mouth Mucosa; Parkinson Disease; Permeability; Swine; Terpenes; Time Factors | 2012 |